Literature DB >> 19627509

Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit.

Luis Ostrosky-Zeichner1, Peter G Pappas, Shmuel Shoham, Annette Reboli, Michelle A Barron, Charles Sims, Craig Wood, Jack D Sobel.   

Abstract

We created a clinical prediction rule to identify patients at risk of invasive candidiasis (IC) in the intensive care unit (ICU) (Eur J Clin Microbiol Infect Dis 2007; 26:271). The rule applies to <10% of patients in ICUs. We sought to create a more inclusive rule for clinical trials. Retrospective review of patients admitted to ICU ≥ 4 days, collecting risk factors and outcomes. Variations of the rule based on introduction of mechanical ventilation and risk factors were assessed. We reviewed 597 patients with a mean APACHE II score of 14.4, mean ICU stay of 12.5 days and mean ventilation time of 10.7 days. A variation of the rule requiring mechanical ventilation AND central venous catheter AND broad spectrum antibiotics on days 1-3 AND an additional risk factor applied to 18% of patients, maintaining the incidence of IC at 10%. Modification of our original rule resulted in a more inclusive rule for studies.
© 2009 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 19627509     DOI: 10.1111/j.1439-0507.2009.01756.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  34 in total

Review 1.  [Invasive candidiasis in non-neutropenic adults : Guideline-based management in the intensive care unit].

Authors:  A Glöckner; O A Cornely
Journal:  Anaesthesist       Date:  2013-12       Impact factor: 1.041

2.  When and how to cover for fungal infections in patients with severe sepsis and septic shock.

Authors:  Nicolas Allou; Jerome Allyn; Philippe Montravers
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

3.  Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation?

Authors:  Francesco Giuseppe De Rosa; Silvia Corcione; Giorgia Montrucchio; Luca Brazzi; Giovanni Di Perri
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-12-01

Review 4.  Invasive Candida Infections in the ICU: Diagnosis and Therapy.

Authors:  Péter Hankovszky; Domokos Társy; Nándor Öveges; Zsolt Molnár
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-11-10

Review 5.  What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients.

Authors:  Cristóbal León; Luis Ostrosky-Zeichner; Mindy Schuster
Journal:  Intensive Care Med       Date:  2014-04-10       Impact factor: 17.440

Review 6.  Invasive fungal infections in patients with cancer in the Intensive Care Unit.

Authors:  Nikolaos V Sipsas; Dimitrios P Kontoyiannis
Journal:  Int J Antimicrob Agents       Date:  2012-02-14       Impact factor: 5.283

7.  Cost-Effectiveness Analysis of Multiplex PCR with Magnetic Resonance Detection versus Empiric or Blood Culture-Directed Therapy for Management of Suspected Candidemia.

Authors:  Brandon Walker; Margaret V Powers-Fletcher; Robert L Schmidt; Kimberly E Hanson
Journal:  J Clin Microbiol       Date:  2016-01-06       Impact factor: 5.948

8.  Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.

Authors:  Jürgen Held; Isabelle Kohlberger; Elfriede Rappold; Andrea Busse Grawitz; Georg Häcker
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

9.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

Review 10.  Invasive fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham; Kieren A Marr
Journal:  Future Microbiol       Date:  2012-05       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.